Search
Descriptor English: Latanoprost
Descriptor Spanish: Latanoprost
Descriptor latanoprost
Entry term(s) PHXA41
PhXA34
Xalatan
Scope note: Análogo de la prostaglandina F que se usa para tratar la HIPERTENSIÓN OCULAR en pacientes con GLAUCOMA.
Descriptor Portuguese: Latanoprosta
Descriptor French: Latanoprost
Entry term(s): PHXA41
PhXA34
Xalatan
Tree number(s): D10.251.355.255.550.775.500.587
D23.469.050.175.725.775.500.587
D23.469.700.670.587
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000077338
Scope note: A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Antihypertensive Agents
Registry Number: 6Z5B6HVF6O
CAS Type 1 Name: Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate
Public MeSH Note: 2019; LATANOPROST was indexed under PROSTAGLANDINS F, SYNTHETIC 1992-2018
History Note: 2019 (1992)
DeCS ID: 57622
Unique ID: D000077338
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2019/01/01
Date of Entry: 2018/07/09
Revision Date: 2018/02/28
Latanoprost - Preferred
Concept UI M0195347
Scope note A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA.
Preferred term Latanoprost
PhXA34 - Narrower
Concept UI M0195346
Preferred term PhXA34
PHXA41 - Narrower
Concept UI M0195345
Preferred term PHXA41
Xalatan - Narrower
Concept UI M0356526
Preferred term Xalatan



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey